Walder Wyss advised Trilantic Europe, in connection with the acquisition of all shares in Axicom HV from German investment company RCP. Pursuant to the deal, it’s Energy Transition Investments, an investment company of Trilantic itself, completing the acquisition. The parties Trilantic Europe is a private equity active across the European continent and specialised in energy […]
Walder Wyss advised Sparta Commodities, a specialist in real-time intelligence for commodity traders, in connection with its USD 42m Series-B financing round. The context One Peak led the capital round in question, with support from
Loyens & Loeff advised Swedish listed Alfa Laval as Swiss counsel on a binding put-option agreement to acquire the Fives Cryogenics business unit, part of the French Fives Group, for a total fixed purchase price
Niederer Kraft Frey (NKF) acted as Swiss counsel to German battery manufacturer Varta in connection with the successful completion of a financial restructuring under the German StaRUG. Pursuant to the transaction, Varta secures EUR 60 million
French automotive distributor BPM completed the acquisition of Renens-based Groupe Leuba. In connection with the deal, Borel & Barbey represented the buyer, while Kellerhals Carrard advised the shareholders of Groupe Leuba. The parties Headquartered in
CMS Switzerland advised Spanish hotel brand and lease management company Room Mate Hotels hotel on its acquisition – by way of a share deal – of the Geneva-based Hotel Marmont’s long leasehold. The context The 4-star
Niederer Kraft Frey (NKF) advised outpatient healthcare provider Affidea on the acquisition of Uroviva Group. Moreover, Advestra advised German Equity Partners IV, a fund managed by the independent German
Lenz & Staehelin advised Vivalto Partners on Swiss tax matters in connection with its acquisition of Linnea, an international pharmaceutical manufacturer of botanical ingredients based in Switzerland. The context Headquartered in Paris, Vivalto Partners is
Walder Wyss advised MedComms Experts (MCE), a global provider of rare-disease-focused medical communications services, in connection with a strategic investment by The Brydon Group (Brydon). The company Headquartered in Zurich, MCE is a multidisciplinary medical
Bär & Karrer advised HAS Healthcare Advanced Synthesis and its sole shareholder in the acquisition of Chemholding due and its subsidiaries, including its main operative company Cerbios-Pharma. The company HAS Healthcare Advanced Synthesis is
